Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4

2(66.7%)

Early Phase 1

1(33.3%)

3Total

Phase 4(2)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02129387Completed

EEG & Behavioral Predictors of Changes in Smoking Trajectories in Young Light Smokers

Role: lead

NCT01625728Completed

Vocal Demands Among Classroom Teachers

Role: lead

NCT01400243Phase 4Completed

Nicotine Patch for Marijuana Withdrawal

Role: lead

NCT01048944Phase 4Completed

Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers

Role: lead

NCT01435837Early Phase 1Completed

Interaction of Caffeine and Hydration on Voice

Role: lead

All 5 trials loaded